Winifred S. Hayes, Inc. Blog FDA Approves First Cannabis-Derived Drug for Treatment of Seizures

Winifred S. Hayes, Inc. Blog FDA's Efforts to Support Value-Based Healthcare

Winifred S. Hayes, Inc. Blog FDA Approves First-in-Class Medicine for Migraine Prevention

Winifred S. Hayes, Inc. Blog FDA Approves New Drug to Treat Thrombocytopenia in Chronic Liver Disease

Winifred S. Hayes, Inc. Blog FDA Approves Palynziq for Treatment of Phenylketonuria

Winifred S. Hayes, Inc. Blog FDA approves new drug for patients with chronic liver disease

Winifred S. Hayes, Inc. Blog FDA Approves First-in-Class Medicine for Prevention of Migraine